|Bid||123.67 x 1100|
|Ask||123.69 x 1000|
|Day's Range||121.25 - 124.61|
|52 Week Range||75.30 - 129.59|
|Beta (5Y Monthly)||1.29|
|PE Ratio (TTM)||19.10|
|Earnings Date||Jul 28, 2021 - Aug 02, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||123.71|
DaVita (DVA) and NKF collaborate to help kidney patients seeking a living donor, thereby improving health equity in kidney transplant process.
The Zacks Analyst Blog Highlights: National Vision, DaVita, Elanco Animal Health, Henry Schein and Phibro Animal Health
Here are some MedTech stocks with favorable PEG ratio, which are expected to provide gains in 2021.